Baidu
map

泌尿外科指南

订阅

MedSci主页 / 所有栏目 / 泌尿外科指南

2022 AUA/SMSNA指南：复发性缺血性阴茎异常勃起，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理

2022-05-10 美国泌尿外科学会 J Urol

阴茎异常勃起

2022年2月，美国泌尿外科学会(AUA)联合北美性医学学会(SMSNA)共同发布了复发性缺血性阴茎异常，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理指南。阴茎异常勃起是一种持续性阴茎勃

中文标题：

2022 AUA/SMSNA指南：复发性缺血性阴茎异常勃起，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理

英文标题：

The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients and Non-Ischemic Priapism: an AUA/SMSNA Guideline

发布机构：

美国泌尿外科学会

发布日期：

2022-05-10

简要介绍：

2022年2月，美国泌尿外科学会(AUA)联合北美性医学学会(SMSNA)共同发布了复发性缺血性阴茎异常，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理指南。阴茎异常勃起是一种持续性阴茎勃起，导致勃起时间延长且不受控制。本文主要针对复发性缺血性阴茎异常勃起，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 AUA_SMSNA指南：复发性缺血性阴茎异常勃起，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=f20451c002a38123, title=2022 AUA/SMSNA指南：复发性缺血性阴茎异常勃起，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理, enTitle=The Diagnosis and Management of Recurrent Ischemic Priapism, Priapism in Sickle Cell Patients and Non-Ischemic Priapism: an AUA/SMSNA Guideline, guiderFrom=J Urol, authorId=0, author=, summary=2022年2月，美国泌尿外科学会(AUA)联合北美性医学学会(SMSNA)共同发布了复发性缺血性阴茎异常，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理指南。阴茎异常勃起是一种持续性阴茎勃, cover=https://img.medsci.cn/20220516/1652679645575_1608702.png, journalId=0, articlesId=null, associationId=87, associationName=美国泌尿外科学会, associationIntro=AUA成立于1902年， 是全球泌尿外科领域最具影响力的学术组织之一，在全球化的背景下，联合世界各地的泌尿专家促进了学术界的最新科学研究以及临床治疗，确保世界各地的患者都能接收到最高水平的治疗。 出版包括Journal of Urology在内的多种重要刊物。, copyright=0, guiderPublishedTime=Tue May 10 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">2022年2月，美国泌尿外科学会(AUA)联合北美性医学学会(SMSNA)共同发布了复发性缺血性阴茎异常，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理指南。阴茎异常勃起是一种持续性阴茎勃起，导致勃起时间延长且不受控制。本文主要针对复发性缺血性阴茎异常勃起，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理提供指导建议。</span></p>, tagList=[TagDto(tagId=13225, tagName=阴茎异常勃起)], categoryList=[CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7011, appHits=57, showAppHits=0, pcHits=241, showPcHits=6952, likes=3, shares=15, comments=3, approvalStatus=1, publishedTime=Mon May 16 15:38:00 CST 2022, publishedTimeString=2022-05-10, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon May 16 13:43:24 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 15:41:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 AUA_SMSNA指南：复发性缺血性阴茎异常勃起，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理.pdf)])
2022 AUA_SMSNA指南：复发性缺血性阴茎异常勃起，镰状细胞患者阴茎异常勃起和非缺血性阴茎异常勃起的诊断和管理.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1220860, encodeId=235212208607e, content=很好的资料，值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cf78170543, createdName=ms5000000043316693, createdTime=Thu May 19 10:02:02 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220637, encodeId=931e122063e78, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Wed May 18 11:50:30 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220636, encodeId=f04c12206366d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Wed May 18 11:49:54 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2022-05-19 ms5000000043316693

    很好的资料，值得学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1220860, encodeId=235212208607e, content=很好的资料，值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cf78170543, createdName=ms5000000043316693, createdTime=Thu May 19 10:02:02 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220637, encodeId=931e122063e78, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Wed May 18 11:50:30 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220636, encodeId=f04c12206366d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Wed May 18 11:49:54 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2022-05-18 ms3000001005882169

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1220860, encodeId=235212208607e, content=很好的资料，值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3cf78170543, createdName=ms5000000043316693, createdTime=Thu May 19 10:02:02 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220637, encodeId=931e122063e78, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Wed May 18 11:50:30 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220636, encodeId=f04c12206366d, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230213/5855e9a7e85e4b808849362164402c52/25868520bd3e4851a7619202ec8728e2.jpg, createdBy=357c6553867, createdName=ms3000001005882169, createdTime=Wed May 18 11:49:54 CST 2022, time=2022-05-18, status=1, ipAttribution=)]
    2022-05-18 ms3000001005882169

    学习了

    0

Baidu
map
Baidu
map
Baidu
map